EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 110 filers reported holding EPIZYME INC in Q1 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $30,000 | -88.0% | 20,509 | -79.6% | 0.00% | -100.0% |
| Q4 2021 | $251,000 | -36.1% | 100,416 | +177.7% | 0.00% | -66.7% |
| Q4 2020 | $393,000 | -59.0% | 36,159 | -55.0% | 0.00% | -76.9% |
| Q3 2020 | $959,000 | -17.1% | 80,371 | +11.5% | 0.01% | -31.6% |
| Q2 2020 | $1,157,000 | +407.5% | 72,057 | +389.9% | 0.02% | +216.7% |
| Q1 2020 | $228,000 | -76.3% | 14,709 | -81.1% | 0.01% | -40.0% |
| Q1 2019 | $963,000 | +118.9% | 77,700 | +8.7% | 0.01% | +100.0% |
| Q4 2018 | $440,000 | +23.2% | 71,453 | +112.0% | 0.01% | +25.0% |
| Q3 2018 | $357,000 | +42.2% | 33,700 | +81.7% | 0.00% | +33.3% |
| Q2 2018 | $251,000 | +0.8% | 18,549 | +32.0% | 0.00% | -25.0% |
| Q1 2018 | $249,000 | -49.5% | 14,052 | -45.7% | 0.00% | -55.6% |
| Q3 2017 | $493,000 | +142.9% | 25,902 | +93.0% | 0.01% | +125.0% |
| Q2 2017 | $203,000 | +23.0% | 13,423 | +30.3% | 0.00% | -77.8% |
| Q4 2015 | $165,000 | – | 10,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |